Vocal Folds Leukoplakia: The Efficacy of Vitamin A in the Initial Treatment

 

 Permissions and Reprints

Abstract

Introduction Laryngeal leukoplakia corresponds to a white lesion in the mucosa developed by the deposit of keratin in the epithelium, potentiated by chronic smoking. It is considered a preneoplastic lesion. Surgery is the most adopted treatment; however, non-surgical treatment is advocated by some authors.

Objective To evaluate the effectiveness of vitamin A in the management of vocal fold leukoplakia.

Methods Patients with videolaryngoscopy diagnosis of vocal fold leukoplakia were selected. The endoscopic images were photographed and with the aid of the ImageJ software (National Institutes of Health, Bethesda, MD, USA), the proportion of the size of the leukoplakia was calculated. Eligible patients were prescribed 50,000U of vitamin A, twice daily for 2 months, at which point videolaryngostroboscopy was repeated for comparative analysis between pre and posttreatment. The efficacy of the treatment was classified as: outcome I – complete improvement of the lesion, outcome II – partial improvement, and outcome III – no difference or increased lesion size.

Results Fifteen patients (eight women, seven men) were included, six of whom had bilateral lesions. Smoking was reported in 86.8% of patients. Complete improvement of the lesion was found in 7 cases (33.4%, outcome I), partial improvement in 6 (28.6%, outcome II), and worsening of the injury in 8 (38.1%, outcome III). Of the latter, 6 underwent microsurgery; histopathology indicated absence of dysplasia in 3, and mild dysplasia in 3.

Conclusions In this study, the treatment with vitamin A at a dose of 100,000 IU daily for 2 months was effective in reducing the laryngeal leukoplakia size in 62% of cases.

Publication History

Received: 26 May 2021

Accepted: 14 December 2021

Article published online:
10 November 2022

© 2023. Fundação Otorrinolaringologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

• References

• 1 Fang TJ, Lin WN, Lee LY. et al. Classification of vocal fold leukoplakia by clinical scoring. Head Neck 2016; 38 (Suppl. 01) E1998-E2003 DOI: 10.1002/hed.24368.
  CrossrefPubMedGoogle Scholar
• 2 Gale N, Gnepp DR, Poljak M. et al. Laryngeal Squamous Intraepithelial Lesions: An Updated Review on Etiology, Classification, Molecular Changes, and Treatment. Adv Anat Pathol 2016; 23 (02) 84-91 DOI: 10.1097/PAP.0000000000000106.
  CrossrefPubMedGoogle Scholar
• 3 Ferlito A, Devaney KO, Woolgar JA. et al. Squamous epithelial changes of the larynx: diagnosis and therapy. Head Neck 2012; 34 (12) 1810-1816 DOI: 10.1002/hed.21862.
  CrossrefPubMedGoogle Scholar
• 4 Isenberg JS, Crozier DL, Dailey SH. Institutional and comprehensive review of laryngeal leukoplakia. Ann Otol Rhinol Laryngol 2008; 117 (01) 74-79 DOI: 10.1177/000348940811700114.
  CrossrefPubMedGoogle Scholar
• 5 Haldorsen T, Martinsen JI, Kjærheim K, Grimsrud TK. Adjustment for tobacco smoking and alcohol consumption by simultaneous analysis of several types of cancer. Cancer Causes Control 2017; 28 (02) 155-165 DOI: 10.1007/s10552-016-0847-x.
  CrossrefPubMedGoogle Scholar
• 6 Mello FW, Melo G, Pasetto JJ, Silva CAB, Warnakulasuriya S, Rivero ERC. The synergistic effect of tobacco and alcohol consumption on oral squamous cell carcinoma: a systematic review and meta-analysis. Clin Oral Investig 2019; 23 (07) 2849-2859 DOI: 10.1007/s00784-019-02958-1.
  CrossrefPubMedGoogle Scholar
• 7 Vaezi MF, Qadeer MA, Lopez R, Colabianchi N. Laryngeal cancer and gastroesophageal reflux disease: a case-control study. Am J Med 2006; 119 (09) 768-776 DOI: 10.1016/j.amjmed.2006.01.019.
  CrossrefPubMedGoogle Scholar
• 8 Park JC, Altman KW, Prasad VMN, Broadhurst M, Akst LM. Laryngeal leukoplakia: state of the art review. Otolaryngol Head Neck Surg 2021; 164 (06) 1153-1159 DOI: 10.1177/0194599820965910.
  CrossrefPubMedGoogle Scholar
• 9 Tavaluc R, Tan-Geller M. Reinke's Edema. Otolaryngol Clin North Am 2019; 52 (04) 627-635 DOI: 10.1016/j.otc.2019.03.006.
  CrossrefPubMedGoogle Scholar
• 10 El-Demerdash A, Fawaz SA, Sabri SM, Sweed A, Rabie H. Sensitivity and specificity of stroboscopy in preoperative differentiation of dysplasia from early invasive glottic carcinoma. Eur Arch Otorhinolaryngol 2015; 272 (05) 1189-1193 DOI: 10.1007/s00405-015-3530-z.
  CrossrefPubMedGoogle Scholar
• 11 Rzepakowska A, Sielska-Badurek E, Osuch-Wójcikiewicz E, Sobol M, Niemczyk K. The predictive value of videostroboscopy in the assessment of premalignant lesions and early glottis cancers. Otolaryngol Pol 2017; 71 (04) 14-18 DOI: 10.5604/01.3001.0010.2243.
  CrossrefPubMedGoogle Scholar
• 12 D'Ambrosio DN, Clugston RD, Blaner WS. Vitamin A metabolism: an update. Nutrients 2011; 3 (01) 63-103 DOI: 10.3390/nu3010063.
  CrossrefPubMedGoogle Scholar
• 13 Nishimoto K, Toya Y, Davis CR, Tanumihardjo SA, Welham NV. Dynamics of vitamin A uptake, storage, and utilization in vocal fold mucosa. Mol Metab 2020; 40: 101025 DOI: 10.1016/j.molmet.2020.101025.
  CrossrefPubMedGoogle Scholar
• 14 Tateya I, Tateya T, Surles RL, Kanehira K, Tanumihardjo S, Bless DM. Vitamin A deficiency causes metaplasia in vocal fold epithelium: a rat study. Ann Otol Rhinol Laryngol 2008; 117 (02) 153-158 DOI: 10.1177/000348940811700214.
  CrossrefPubMedGoogle Scholar
• 15 Hong WK, Endicott J, Itri LM. et al. 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med 1986; 315 (24) 1501-1505 DOI: 10.1056/NEJM198612113152401.
  CrossrefPubMedGoogle Scholar
• 16 Lodi G, Franchini R, Warnakulasuriya S. et al. Interventions for treating oral leukoplakia to prevent oral cancer. Cochrane Database Syst Rev 2016; 7 (07) CD001829 DOI: 10.1002/14651858.CD001829.
  CrossrefPubMedGoogle Scholar
• 17 Sankaranarayanan R, Mathew B, Varghese C. et al. Chemoprevention of oral leukoplakia with vitamin A and beta carotene: an assessment. Oral Oncol 1997; 33 (04) 231-236 DOI: 10.1016/s0964-1955(97)00010-9.
  CrossrefPubMedGoogle Scholar
• 18 Stich HF, Hornby AP, Mathew B, Sankaranarayanan R, Nair MK. Response of oral leukoplakias to the administration of vitamin A. Cancer Lett 1988; 40 (01) 93-101 DOI: 10.1016/0304-3835(88)90266-2.
  CrossrefPubMedGoogle Scholar
• 19 Bell R, Hong WK, Itri LM, McDonald G, Strong MS. The use of cis-retinoic acid in recurrent respiratory papillomatosis of the larynx: a randomized pilot study. Am J Otolaryngol 1988; 9 (04) 161-164 DOI: 10.1016/s0196-0709(88)80023-1.
  CrossrefPubMedGoogle Scholar
• 20 Camacho LH. Clinical applications of retinoids in cancer medicine. J Biol Regul Homeost Agents 2003; 17 (01) 98-114
  PubMedGoogle Scholar
• 21 Meyskens Jr FL, Gilmartin E, Alberts DS. et al. Activity of isotretinoin against squamous cell cancers and preneoplastic lesions. Cancer Treat Rep 1982; 66 (06) 1315-1319
  Google Scholar
• 22 Lippman SM, Garewal HS, Meyskens Jr FL. Retinoids as potential chemopreventive agents in squamous cell carcinoma of the head and neck. Review Prev Med 1989; 18 (05) 740-748 DOI: 10.1016/0091-7435(89)90045-5.
  CrossrefPubMedGoogle Scholar
• 23 Issing WJ, Struck R, Naumann A. Long-term follow-up of larynx leukoplakia under treatment with retinyl palmitate. Head Neck 1996; 18 (06) 560-565 DOI: 10.1002/(SICI)1097-0347(199611/12)18:6<560:AID-HED11>3.0.CO;2-C.
  CrossrefPubMedGoogle Scholar
• 24 Okur E, Kahveci OK, Aycicek A, Altuntaş A. The effect of retinyl palmitate on healing of benign vocal fold lesions. Eur Arch Otorhinolaryngol 2013; 270 (01) 239-242 DOI: 10.1007/s00405-012-2163-8.
  CrossrefPubMedGoogle Scholar
• 25 Garcia Martins RH, Marques Madeira SL, Fabro AT, Rocha NdeS, de Oliveira Semenzati G, Alves KF. Effects to exposure of tobacco smoke and alcohol on the tongue and pharynx of rats. Inhal Toxicol 2012; 24 (03) 153-160 DOI: 10.3109/08958378.2011.649190.
  CrossrefPubMedGoogle Scholar
• 26 Jackler RK, VanWinkle CK, Bumanlag IM, Ramamurthi D. Alcohol-flavoured tobacco products. Tob Control 2018; 27 (03) 294-300 DOI: 10.1136/tobacco.
  CrossrefGoogle Scholar
• 27 Chen M, Cheng L, Li CJ, Chen J, Shu YL, Wu HT. Nonsurgical Treatment for Vocal Fold Leukoplakia: An Analysis of 178 Cases. BioMed Res Int 2017; 2017: 6958250 DOI: 10.1155/2017/6958250.
  CrossrefPubMedGoogle Scholar
• 28 Sezen Goktas S, Dogan R, Yenigun A, Calim OF, Ozturan O, Tugrul S. A new approach to vocal cord leukoplakia and evaluation of proton pump ınhibitor treatment. Eur Arch Otorhinolaryngol 2019; 276 (02) 467-471 DOI: 10.1007/s00405-018-05273-9.
  CrossrefPubMedGoogle Scholar
• 29 Li X, Huang Z, Wu T, Wang L, Wu J. [Role of laryngopharyngeal reflux on the pathogenesis of vocal cord leukoplakia and early glottic cancer]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2014; 49 (05) 362-367
  PubMedGoogle Scholar